Purpose: To assess choroidal thickness (CT) and its relationship to retinal sensitivity in mild/moderate age-related macular degeneration (AMD). Methods: Seventy-two eyes of 51 participants with mild/moderate AMD and 36 eyes of 18 age-matched normal participants were prospectively recruited to undergo enhanced-depth imaging optical coherence tomography (EDI-OCT) imaging and microperimetry (MP) functional assessment. OCT-measured CT and retinal thickness (RT) were matched with MP sensitivity at 13 retinal loci, and correlations were analysed. Results: Patients with AMD had an average RT 56.5 μm greater than those without AMD (p < 0.001). There was no significant difference in CT between normal and AMD participants (p = 0.36). In patients without atrophy or pigment epithelial detachment, there was no correlation between MP sensitivity and CT (p = 0.08); however, a correlation between RT and MP was detected (b = 0.006, p = 0.046). Among patients without AMD, MP sensitivity was positively correlated with RT (b = 0.007, p < 0.001) and negatively correlated with CT (b = 0.0046, p = 0.035). Conclusions: CT does not correlate with retinal sensitivity in AMD. Although choroidal damage and impaired choroidal perfusion appear to be important concepts in AMD pathogenesis, increasing choroidal thinning may not be associated with worsening retinal function in AMD.

Keywords:
Age-related macular degeneration, Choroid, Microperimetry
1.
van Lookeren Campagne M, LeCouter J, Yaspan BL, Ye W: Mechanisms of age-related macular degeneration and therapeutic opportunities. J Pathol 2014;232:151-164.
2.
Klein R, Lee KE, Gangnon RE, Klein BE: Incidence of visual impairment over a 20-year period: the Beaver Dam Eye Study. Ophthalmology 2013;120:1210-1219.
3.
Whitmore SS, Sohn EH, Chirco KR, et al: Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. Prog Retin Eye Res 2015;45:1-29.
4.
Bird AC, Phillips RL, Hageman GS: Geographic atrophy: a histopathological assessment. JAMA Ophthalmol 2014;132:338-345.
5.
Riva CE, Geiser M, Petrig BL: Ocular blood flow assessment using continuous laser Doppler flowmetry. Acta Ophthalmol 2010;88:622-629.
6.
Spaide RF, Koizumi H, Pozzoni MC: Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 2008;146:496-500.
7.
Ishikawa S, Taguchi M, Muraoka T, Sakurai Y, Kanda T, Takeuchi M: Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behcet's disease. Br J Ophthalmol 2014;98:1508-1513.
8.
Esmaeelpour M, Brunner S, Ansari-Shahrezaei S, et al: Choroidal thinning in diabetes type 1 detected by 3-dimensional 1,060 nm optical coherence tomography. Invest Ophthalmol Vis Sci 2012;53:6803-6809.
9.
Adhi M, Lau M, Liang MC, Waheed NK, Duker JS: Analysis of the thickness and vascular layers of the choroid in eyes with geographic atrophy using spectral-domain optical coherence tomography. Retina 2014;34:306-312.
10.
Jonas JB, Forster TM, Steinmetz P, Schlichtenbrede FC, Harder BC: Choroidal thickness in age-related macular degeneration. Retina 2014;34:1149-1155.
11.
Lee JY, Lee DH, Lee JY, Yoon YH: Correlation between subfoveal choroidal thickness and the severity or progression of nonexudative age-related macular degeneration. Invest Ophthalmol Vis Sci 2013;54:7812-7818.
12.
Zaben A, Zapata MA, Garcia-Arumi J: Retinal sensitivity and choroidal thickness in high myopia. Retina 2015;35:398-406.
13.
Wu Z, Ayton LN, Luu CD, Guymer RH: Relationship between retinal microstructures on optical coherence tomography and microperimetry in age-related macular degeneration. Ophthalmology 2014;121:1445-1452.
14.
Wu Z, Ayton LN, Luu CD, Guymer RH: Microperimetry of nascent geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 2014;56:115-121.
15.
Parravano M, Oddone F, Giorno P, et al: Influence of macular choroidal thickness on visual function in highly myopic eyes. Ophthalmic Res 2014;52:97-101.
16.
Age-Related Eye Disease Study Research Group: The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 2001;132:668-681.
17.
Sigler EJ, Randolph JC: Comparison of macular choroidal thickness among patients older than age 65 with early atrophic age-related macular degeneration and normals. Invest Ophthalmol Vis Sci 2013;54:6307-6313.
18.
Ouyang Y, Heussen FM, Hariri A, Keane PA, Sadda SR: Optical coherence tomography-based observation of the natural history of drusenoid lesion in eyes with dry age-related macular degeneration. Ophthalmology 2013;120:2656-2665.
19.
Yiu G, Chiu SJ, Petrou PA, et al: Relationship of central choroidal thickness with age-related macular degeneration status. Am J Ophthalmol 2015;159:617-626.
20.
Sogawa K, Nagaoka T, Takahashi A, et al: Relationship between choroidal thickness and choroidal circulation in healthy young subjects. Am J Ophthalmol 2012;153:1129-1132.e1.
21.
Kim M, Kim SS, Kwon HJ, Koh HJ, Lee SC: Association between choroidal thickness and ocular perfusion pressure in young, healthy subjects: enhanced depth imaging optical coherence tomography study. Invest Ophthalmol Vis Sci 2012;53:7710-7717.
22.
Alten F, Heiduschka P, Clemens CR, Eter N: Longitudinal structure/function analysis in reticular pseudodrusen. Invest Ophthalmol Vis Sci 2014;55:6073-6081.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.